Taiflex Scientific revenue and financials
$303.50Change from previous close: +2.53%Absolute change: +$7.50
In the fiscal year ended December 2025, Taiflex Scientific reported revenue of $10.61B (+6.75% year over year). Net income was $535.12M, a net margin of 5.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +6.75%
- 2025 vs 2024
- Net income growth
- −9.73%
- 2025 vs 2024
- Net margin
- 5.0%
- 2024: 6.0%
Financial data
Amounts in millions of TWD; per-share values in TWD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 10,609 | 9,938 | 8,151 | 8,722 |
| Cost of revenue | 8,568 | 7,800 | 6,359 | 6,643 |
| Gross profit | 2,041 | 2,138 | 1,792 | 2,079 |
| Selling, general and administrative | 1,063 | 1,052 | 934 | 1,024 |
| Research and development | 459 | 394 | 367 | 401 |
| Operating income | 519 | 691 | 491 | 654 |
| EBIT | 637 | 732 | 515 | 913 |
| EBITDA | 1,184 | 1,262 | 974 | 1,344 |
| Interest expense | 22.6 | 31.3 | 32.5 | 35.2 |
| Pre-tax income | 615 | 701 | 482 | 877 |
| Income tax | 89.7 | 169 | 122 | 186 |
| Net income | 535 | 593 | 423 | 700 |
| Net income to common shareholders | 535 | 593 | 423 | 700 |
| Basic EPS | 2.07 | 2.53 | 1.93 | 3.20 |
| Diluted EPS | 2.04 | 2.32 | 1.66 | 2.74 |
| Average shares (basic) | 259 | 235 | 219 | 219 |
| Average shares (diluted) | 264 | 259 | 263 | 261 |